Carey Ng - Sep 14, 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Carey Ng
Stock symbol
IMMX
Transactions as of
Sep 14, 2023
Transactions value $
$25,760
Form type
4
Date filed
9/15/2023, 06:27 PM
Previous filing
Aug 14, 2023
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Purchase $25.8K +10K $2.58 10K Sep 14, 2023 Direct F1
holding IMMX Common Stock 1.03M Sep 14, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2 Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP ("Mesa Verde") and in such capacity has the right to vote and dispose of the securities held by such entity.